Medicis Pharmaceutical Corp. (MRX) Tops Q2 EPS by 39c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.12 +1.79%
Financial Fact:
Operating income (loss): 15.78M
Today's EPS Names:
RBRK, TITN, LOT, More
Financial Fact:
Operating income (loss): 15.78M
Today's EPS Names:
RBRK, TITN, LOT, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q2 EPS of $1.64, $0.39 better than the analyst estimate of $1.25. Revenue for the quarter came in at $695.8 million versus the consensus estimate of $595.88 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GSX Techedu Inc. (GOTU) Misses Q2 EPS by 11c; offers guidance
- Berenberg Upgrades Vestas Wind Systems A/S (VWS:DC) (VWDRY) to Buy
- CrowdStrike shares jump on earnings beat, raised outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
